MONSTER BEVERAGE CORP (MNST)       100.04  -1.5 (-1.48%)

100.04  -1.5 (-1.48%)

US61174X1090 - Common Stock - After market: 100.04 0 (0%)


Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MNST. MNST was compared to 40 industry peers in the Beverages industry. While MNST has a great health rating, its profitability is only average at the moment. MNST is quite expensive at the moment. It does show a decent growth rate.




Profitability

Profitability Rating

6

MNST's Return On Assets of 15.00% is amongst the best returns of the industry. MNST outperforms 97% of its industry peers. The industry average Return On Assets is 1.85%.
MNST's Profit Margin of 20.40% is amongst the best returns of the industry. MNST outperforms 81% of its industry peers. The industry average Profit Margin is 8.88%.

MNST has a Return On Equity of 18.01%. This is comparable to the industry average of 18.01%.
The Piotroski-F score of MNST is 4.00. This is a neutral score and indicates average health and profitability for MNST.
VS Industry

ROA (15%) VS Industry: 97% outperformed.

-155.26
30.77

ROE (18.01%) VS Industry: 52% outperformed.

1.11
53.07

Profit Margin (20.4%) VS Industry: 81% outperformed.

1.03
23.44

Valuation

Valuation Rating

0

With a price book ratio of 7.67, MNST is valued correctly.
With a Price/Earnings Ratio of 43.69, MNST can be considered very expensive at the moment.
With a Price/Earning Ratio of 43.69, MNST is valued a higher than the industry average, which is at 24.69. 87% of the companies listed in the same industry are cheaper than MNST!
The Forward Price/Earnings Ratio of 32.63 indicates a quite expensive current valuation of MNST.

The high PEG Ratio, which compensates the Price/Earnings for growth, indicates MNST does not grow enough to justify the current Price/Earnings ratio.
When comparing the price book ratio of MNST to the average industry price book ratio of 2.66, MNST is valued more expensive than its industry peers.
When comparing the Enterprise Value to EBITDA ratio of MNST to the average industry ratio of 15.81, MNST is valued more expensive than its industry peers. 96% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Earnings (43.69) VS Industry: 13% outperformed.

168.51
4.13

Price/Book (7.67) VS Industry: 23% outperformed.

17.70
0.17

Enterprise Value/ EBITDA (29.13) VS Industry: 4% outperformed.

133.43
6.06

Growth

Growth Rating

5

MNST shows quite a strong growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 14.60% yearly.
The Earnings Per Share is expected to grow by 15.55% on average over the next 5 years. This is quite good.
Looking at the last year, MNST shows a quite strong growth in Revenue. The Revenue has grown by 16.72% in the last year.
Measured over the past 5 years, MNST shows a quite strong growth in Revenue. The Revenue has been growing by 12.69% on average per year.

The EPS growth is stable: in the next 5 years the growth will be about the same than in the last 5 years.
The Revenue is expected to grow by 9.09% on average over the next 5 years.
MNST shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.26%.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS14.6% 12.6% -12.26% -8.19% 9.22% 11.51% 15.55%
Revenue12.69% 13.33% 16.72% 18.32% 14.36% 13.23% 9.09%

Health

Health Rating

9

A Current Ratio of 4.29 indicates that MNST has no problem at all paying its short term obligations.
MNST is one of the better placed companies in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.49. MNST has a better rating than 89% of its industry peers.
MNST has a Quick Ratio of 3.48. This indicates that MNST is financially healthy and has no problem in meeting its short term obligations.
The Quick Ratio of MNST is much better than the industry average of 0.95. MNST has a better rating than 94% of its industry peers.

With a Debt to Equity ratio of 0.00, MNST is one of the better performing companies in its industry. It outperforms 83% of its industry peers.
MNST has an Altman-Z score of 26.63. This indicates that MNST is financially healthy and little risk of bankruptcy at the moment.
MNST has one of the better Altman-Z scores in its industry. It is much better than the industry average of 2.60. MNST has a better score than 100% of its industry peers.
The Piotroski-F score of MNST is 4.00. This is a neutral score and indicates average health and profitability for MNST.
VS Industry

Debt/Equity (0) VS Industry: 83% outperformed.

1.91
0.00

Quick Ratio (3.48) VS Industry: 94% outperformed.

0.14
6.04

Current Ratio (4.29) VS Industry: 89% outperformed.

0.60
7.07

Altman-Z (26.63) VS Industry: 100% outperformed.

-168.90
26.63

Dividend

Dividend Rating

0

MNST does not give a dividend.

MNST Daily chart

MONSTER BEVERAGE CORP100.04

NASDAQ:MNST (12/9/2022, 5:58:39 PM)-1.5 (-1.48%)

After market: 100.04 0 (0%)

Chartmill FA Rating
GICS Sector Consumer Staples
GICS IndustryGroup Food, Beverage & Tobacco
GICS Industry Beverages
Earnings (Last) 11-03 2022-11-03/amc Earnings (Next) 02-22 2023-02-22
Ins Owners 0.29% Inst Owners 67.19%
Market Cap 52.20B Analysts 77.33
Valuation
PE 43.69 Fwd PE 32.63
PEG (NY) N/A PEG (5Y) 2.99
P/S 8.69 P/B 7.67
EV/EBITDA 29.13
Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A
Growth
EPS 1Y -12.26% EPS 3Y 12.6%
EPS 5Y 14.6% EPS growth Q2Q -32%
EPS Next Y -8.19% EPS Next 2Y 9.22%
EPS Next 3Y 11.51% EPS Next 5Y 15.55%
Revenue growth 1Y 16.72% Revenue growth 3Y 13.33%
Revenue growth 5Y 12.69% Revenue growth Q2Q 13.22%
Revenue Next Year 18.32% Revenue Next 2Y 14.36%
Revenue Next 3Y 13.23% Revenue Next 5Y 9.09%
Health
Current Ratio 4.29 Quick Ratio 3.48
Altman-Z 26.63 F-Score 4
Debt/Equity 0 WACC 9.36%
ROIC/WACC 7.22
Profitability
ROA 15% ROE 18.01%
ROICexgc 67.52% ROIC 18.84%
PM 20.4% OM 27.21%
Asset Turnover 0.74

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA